Each of the campaigns targeted by the Advertising Standards Authority emphasizes the oil companies’ ambitions on renewable energy.
Amundi’s China Head Sets Sights on $25 Trillion Pension Prize After a roller-coaster year in China in which Amundi SA still eked out a profit, Europe’s biggest money manager is eying a more stable prize: a slice of the fledging pension market that may one day be worth $25 trillion.
Chinese Used ByteDance ‘God Credential’ to Track Data, Suit Says Chinese Communist Party members used a “god credential” at TikTok parent ByteDance Inc. to examine the personal data of civil rights activists and protesters in Hong Kong, and identify and track them down, a former company executive said in a court filing.
The stock price of Japanese drug maker Daiichi Sankyo has risen five fold since 2017 after successful launch of its breast cancer drug Enhertu that can potentially replace chemotherapy. The drug is jointly developed and marketed with British drug maker AstraZeneca and the profit is shared. Now, Daiichi Sankyo President Hiroyuki Okuzawa who took the position in April, told Bloomberg exclusively that the company is expanding its sales and development staff overseas, aiming to boost production capacity so that it can handle its cancer drugs business entirely on its own. Okuzawa also expressed confidence in getting a positive study result for these cancer drugs in coming months. (Source: Bloomberg)
